Disarm Therapeutics
VerifiedCreating breakthrough therapeutics to treat patients with neurological diseases by preventing axonal degeneration.
Launch date
Market cap
-
Net debt
-
Enterprise valuation
$120—180m (Dealroom.co estimates Sep 2017.)
Cambridge Massachusetts (HQ)
Authorizing premium user...